We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.39B
AUM Growth
+$25.4M
Cap. Flow
+$14.9M
Cap. Flow %
1.07%
Top 10 Hldgs %
54.48%
Holding
46
New
4
Increased
7
Reduced
25
Closed
1

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$22.3M
2
SBUX icon
Starbucks
SBUX
+$11.8M
3
MDT icon
Medtronic
MDT
+$5.97M
4
AMGN icon
Amgen
AMGN
+$490K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$395K

Top Sells

Rank Stock Value
1
EXPD icon
Expeditors International
EXPD
+$17.2M
2
MSFT icon
Microsoft
MSFT
+$6.24M
3
VAR
Varian Medical Systems, Inc.
VAR
+$5.71M
4
CHRW icon
C.H. Robinson
CHRW
+$3.29M
5
AAPL icon
Apple
AAPL
+$2.81M

Sector Composition

Rank Sector Weight
1 Technology 35.05%
2 Healthcare 15.03%
3 Industrials 12.78%
4 Consumer Staples 11.75%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
26
Becton Dickinson
BDX
$50B
$25.2M 1.81%
108,005
-6,948
-6% -$1.55M
OMC icon
27
Omnicom Group
OMC
$23.5B
$11.7M 0.84%
153,948
-8,121
-5% -$600K
AMGN icon
28
Amgen
AMGN
$225B
$1.33M 0.1%
7,231
+2,769
+62% +$490K
DEO icon
29
Diageo
DEO
$52.2B
$1.25M 0.09%
8,713
+720
+9% +$103K
V icon
30
Visa
V
$671B
$836K 0.06%
6,311
-3
-0% -$386
PAYX icon
31
Paychex
PAYX
$42.8B
$509K 0.04%
7,445
– –
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.19T
$479K 0.03%
8,580
+1,860
+28% +$101K
MNR
33
DELISTED
Monmouth Real Estate Investment Corp
MNR
$455K 0.03%
27,545
– –
INTC icon
34
Intel
INTC
$509B
$407K 0.03%
8,185
-1,165
-12% -$61.9K
OKE icon
35
Oneok
OKE
$58.3B
$368K 0.03%
5,269
– –
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$316K 0.02%
5,710
– –
MMP
37
DELISTED
Magellan Midstream Partners, L.P.
MMP
$311K 0.02%
4,500
– –
MO icon
38
Altria Group
MO
$107B
$301K 0.02%
5,300
– –
XOM icon
39
ExxonMobil
XOM
$657B
$289K 0.02%
+3,495
New +$278K
BRK.A icon
40
Berkshire Hathaway Class A
BRK.A
$1.09T
$282K 0.02%
1
– –
TPR icon
41
Tapestry
TPR
$31.1B
$262K 0.02%
5,605
– –
PFE icon
42
Pfizer
PFE
$150B
$253K 0.02%
7,346
– –
K
43
DELISTED
Kellanova
K
$211K 0.02%
+3,216
New +$191K
ENB icon
44
Enbridge
ENB
$112B
$205K 0.01%
+5,739
New +$182K
CL icon
45
Colgate-Palmolive
CL
$73.6B
– –
-3,393
Closed -$243K
1
2

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return

Saratoga Research & Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Saratoga Research & Investment Management held 46 positions worth $1.39B, up 1.9% from $1.37B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Saratoga Research & Investment Management's Q2 2018 filing shows 4 new, 7 increased, 25 reduced and 1 closed positions. Its largest new stake was ExxonMobil: 3,495 shares worth $289K. The largest sale was Expeditors International, an estimated $17.2M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

  • Saratoga Research & Investment Management's largest Q2 2018 buy was ExxonMobil: 3,495 shares worth $289K.
  • Saratoga Research & Investment Management added most to IBM in Q2 2018, an estimated $22.3M increase.
  • Saratoga Research & Investment Management's biggest Q2 2018 reduction was Expeditors International, cutting an estimated $17.2M.
  • Saratoga Research & Investment Management fully exited Colgate-Palmolive in Q2 2018, selling an estimated $243K.
  • Saratoga Research & Investment Management's ten largest holdings make up 54% of its $1.39B portfolio in Q2 2018.
  • Saratoga Research & Investment Management opened 4 new positions and closed 1 in Q2 2018.
  • Saratoga Research & Investment Management's portfolio value rose 1.9% quarter-over-quarter to $1.39B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2018, filed 17 Jul 2018.